Making Science S A : Presentación Foro MEDCAP 2022

Madrid, 24 de Mayo de 2022

MAKING SCIENCE GROUP, S.A. (la "Sociedad", la "Compañía", el "Grupo", o "Making Science") en virtud de lo previsto en el artículo 17 del Reglamento (UE) nº 596/2014 sobre abuso de mercado y en el artículo 227 del texto refundido de la Ley de Mercado de Valores, aprobado por el Real Decreto Legislativo 4/2015, de 23 de octubre, y disposiciones concordantes, así como en la Circular 3/2020 del segmento BME Growth de BME MTF Equity, por medio de la presente pone en conocimiento la siguiente información:

OTRA INFORMACIÓN RELEVANTE

Con motivo de la participación de Making Science en el Foro MEDCAP 2022 (evento organizado por Bolsas y Mercados Españoles), se adjunta presentación corporativa que se utilizará en dicho foro entre el 24 y 26 de mayo de 2022.

En cumplimiento de lo dispuesto en la Circular 3/2020 del segmento BME Growth de BME MTF Equity, se deja expresa constancia de que la información comunicada por la presente ha sido elaborada bajo la exclusiva responsabilidad de la Compañía y sus administradores.

Quedamos a su disposición para cualquier cuestión adicional.

Atentamente,

Consejero Delegado de Making Science Group, S.A.

José Antonio Martínez Aguilar

Foro Medcap 2022

Investor Presentation

José Antonio Martínez Aguilar

CEO Making Science

May 26, 2022

Disclaimer

2

making science | Investors

Disclaimer

This document and the conference-call webcast (including the Q&A session) may contain forward-looking statements and information (hereinafter, the "Information") relating to MAKING SCIENCE GROUP, S.A (hereinafter "Making Science" or the "Company"). This information may include financial forecasts and estimates based on assumptions or statements regarding plans, objectives and expectations that make reference to different matters, such as the customer base and its evolution, organic growth, potential acquisitions, the Company's results and other aspects related to the activity and financial situation of the Company. The Information can be identified in some cases through the use of words such as "forecast", "expectation", "anticipation", "projection", "estimates", "plan" or similar expressions or variations of such expressions.

The Information reflects the current view of Making Science with respect to future events, and as such, do not represent any guarantee of future certain fulfilment, and are subject to risks and uncertainties that could cause the final developments and results to materially differ from those expressed or implied by such Information. These risks and uncertainties include those identified in the documents containing more comprehensive information filed by Making Science, such as Annual Accounts or the Information Document (Jan. 2020)

Except as required by applicable law, Making Science does not assume any obligation to publicly update the Information to adapt it to events or circumstances taking place after the date of this presentation, including changes in the Company's strategy or any other circumstance.

This document and the conference-call webcast (including the Q&A session) contains or might contain non-audited financial information as prepared by management of the Company. The Information contained herein should therefore be considered as a whole and in conjunction with all the public information regarding the Company available, including any other documents released by the Company that may contain more detailed information. Neither this document nor the conference-call webcast (including the Q&A session) constitute an offer to purchase, sell or exchange any shares, a solicitation of any offer to purchase, sell or exchange any shares, or a recommendation or advice regarding any shares.

Making Science Group, SA - Confidential

Investor Presentation

making science | Investors

Index

3

2021 Year in Review and Q1 Update

1. About Making Science
2. 2021 Highlights
3. Financial Update
4. Q1 Update Appendix

Making Science Group, SA - Confidential

making science | Investors

01. About Making Science